Nok Therapeutics, Inc. — Form D/A
Nok Therapeutics, Inc. of CRANBERRY TWP., PA, a company, filed a Form D amendment with the SEC on 2026-04-22. The offering totals $750K, of which $649K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-04-22
- Form: D/A
- Accession: 0001213900-26-046528
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $750K
- Amount sold: $649K
- Remaining: $101K
- Minimum investment: $500
- Investors: 17
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-562018
Issuer
- Name: Nok Therapeutics, Inc.
- CIK: 0002038166
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Incorporated: 2024
- Address: 2009 MACKENZIE WAY SUITE 100, CRANBERRY TWP., PA, 16066
- Phone: 888-691-5839
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Robert Lewis | Director | Madison, MS |
| Robert Lewis | Executive Officer | Madison, MS |
| Robert Lewis | Promoter | Madison, MS |
| Robert Lewis | Related Person | Madison, MS |
| Brian Cogley | Director | Cranberry Twp, PA |
| Brian Cogley | Executive Officer | Cranberry Twp, PA |
| Brian Cogley | Related Person | Cranberry Twp, PA |
| Michael Lewis | Promoter | Boulder, CO |
| Michael Lewis | Related Person | Boulder, CO |
| David Mehalick | Promoter | Naples, FL |
| David Mehalick | Related Person | Naples, FL |
| Bruce Cassidy | Director | Sarasota, FL |
| Bruce Cassidy | Related Person | Sarasota, FL |
| Martin Lewis | Director | Plainview, TX |
| Martin Lewis | Related Person | Plainview, TX |
Other filings by this issuer (7)
More